Clinical Trial: The CanISleepinMS Study: Effect of Cannabidiol (CBD) on Sleep Quality in Patients With Multiple Sclerosis

U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07840924) titled 'The CanISleepinMS Study: Effect of Cannabidiol (CBD) on Sleep Quality in Patients With Multiple Sclerosis' on Sept. 14.

Brief Summary: Evaluating the effect of 300 mg purified cannabidiol (CBD) on sleep quality in patients with multiple sclerosis (MS).

Study Start Date: March 26, 2024

Study Type: INTERVENTIONAL

Condition: Sleep Quality Multiple Sclerosis Insomnia

Intervention: DRUG: Cannabidiol Oil

This study aims to compare the efficacy of CBD oil with a placebo to manage nocturnal sleep quality in MS patients.

Recruitment Status: COMPLETED

Sponsor: Wageningen University

Information provided by (Responsible Party): Renge...